NM_013382.7:c.1654-217A>G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_013382.7(POMT2):​c.1654-217A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.333 in 148,644 control chromosomes in the GnomAD database, including 9,665 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.33 ( 9665 hom., cov: 33)

Consequence

POMT2
NM_013382.7 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.81

Publications

4 publications found
Variant links:
Genes affected
POMT2 (HGNC:19743): (protein O-mannosyltransferase 2) The protein encoded by this gene is an O-mannosyltransferase that requires interaction with the product of the POMT1 gene for enzymatic function. The encoded protein is found in the membrane of the endoplasmic reticulum. Defects in this gene are a cause of Walker-Warburg syndrome (WWS).[provided by RefSeq, Oct 2008]
POMT2 Gene-Disease associations (from GenCC):
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • myopathy caused by variation in POMT2
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
  • autosomal recessive limb-girdle muscular dystrophy type 2N
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy with cerebellar involvement
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy with intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscle-eye-brain disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 14-77280680-T-C is Benign according to our data. Variant chr14-77280680-T-C is described in ClinVar as Benign. ClinVar VariationId is 668037.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.453 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_013382.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMT2
NM_013382.7
MANE Select
c.1654-217A>G
intron
N/ANP_037514.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMT2
ENST00000261534.9
TSL:1 MANE Select
c.1654-217A>G
intron
N/AENSP00000261534.4Q9UKY4-1
POMT2
ENST00000682795.1
c.1654-217A>G
intron
N/AENSP00000507574.1A0A804HJN3
POMT2
ENST00000923942.1
c.1654-217A>G
intron
N/AENSP00000594001.1

Frequencies

GnomAD3 genomes
AF:
0.334
AC:
49535
AN:
148528
Hom.:
9654
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.117
Gnomad AMI
AF:
0.410
Gnomad AMR
AF:
0.421
Gnomad ASJ
AF:
0.319
Gnomad EAS
AF:
0.467
Gnomad SAS
AF:
0.259
Gnomad FIN
AF:
0.493
Gnomad MID
AF:
0.261
Gnomad NFE
AF:
0.410
Gnomad OTH
AF:
0.343
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.333
AC:
49559
AN:
148644
Hom.:
9665
Cov.:
33
AF XY:
0.338
AC XY:
24486
AN XY:
72476
show subpopulations
African (AFR)
AF:
0.117
AC:
4582
AN:
39278
American (AMR)
AF:
0.421
AC:
6339
AN:
15048
Ashkenazi Jewish (ASJ)
AF:
0.319
AC:
1101
AN:
3450
East Asian (EAS)
AF:
0.468
AC:
2362
AN:
5044
South Asian (SAS)
AF:
0.258
AC:
1180
AN:
4572
European-Finnish (FIN)
AF:
0.493
AC:
5131
AN:
10414
Middle Eastern (MID)
AF:
0.245
AC:
70
AN:
286
European-Non Finnish (NFE)
AF:
0.410
AC:
27704
AN:
67592
Other (OTH)
AF:
0.350
AC:
721
AN:
2060
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1576
3151
4727
6302
7878
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
488
976
1464
1952
2440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.379
Hom.:
20761
Bravo
AF:
0.317
Asia WGS
AF:
0.345
AC:
1196
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.19
DANN
Benign
0.61
PhyloP100
-1.8
PromoterAI
0.0029
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2098380; hg19: chr14-77747023; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.